Centaurus Financial’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-17,612
| Closed | -$155K | – | 866 |
|
|
2023
Q4 | $155K | Sell |
17,612
-6,915
| -28% | -$60.9K | 0.01% | 649 |
|
|
2023
Q3 | $281K | Buy |
24,527
+7,242
| +42% | +$83K | 0.02% | 484 |
|
|
2023
Q2 | $437K | Buy |
17,285
+1,404
| +9% | +$35.5K | 0.04% | 385 |
|
|
2023
Q1 | $512K | Buy |
15,881
+688
| +5% | +$22.2K | 0.04% | 387 |
|
|
2022
Q4 | $280K | Sell |
15,193
-1,217
| -7% | -$22.4K | 0.03% | 509 |
|
|
2022
Q3 | $443K | Sell |
16,410
-3,838
| -19% | -$104K | 0.04% | 371 |
|
|
2022
Q2 | $280K | Sell |
20,248
-442
| -2% | -$6.11K | 0.03% | 511 |
|
|
2022
Q1 | $403K | Sell |
20,690
-188
| -0.9% | -$3.66K | 0.03% | 469 |
|
|
2021
Q4 | $341K | Sell |
20,878
-30,342
| -59% | -$496K | 0.03% | 543 |
|
|
2021
Q3 | $1.43M | Buy |
51,220
+1,403
| +3% | +$39.1K | 0.12% | 205 |
|
|
2021
Q2 | $1.48M | Sell |
49,817
-760
| -2% | -$22.5K | 0.12% | 198 |
|
|
2021
Q1 | $1.41M | Sell |
50,577
-3,262
| -6% | -$91.2K | 0.14% | 175 |
|
|
2020
Q4 | $1.53M | Sell |
53,839
-7,075
| -12% | -$201K | 0.16% | 158 |
|
|
2020
Q3 | $1.53M | Buy |
+60,914
| New | +$1.53M | 0.21% | 112 |
|